Arthneeti
All Q2 FY27 results →
QH

Quick Heal Technologies Ltd

Q2 FY27IT - Software

Quick Heal Technologies Q2 Results 2026 (FY27): Revenue ₹64.9 Cr, PAT ₹5.8 Cr

Q2 FY27 results statement: what the company reported on revenue, margins and capex.

Price₹138
Market cap₹750 Cr
Updated28 Oct 2026
Read4 min read

Quick Heal Technologies Ltd Q2 FY27 key numbers

Revenue
Q2 FY27 Revenue: ₹64.9 Cr, down 22.3% YoY.

As stated in Quick Heal Technologies Ltd's Q2 FY27 results statement · published 28 Oct 2026. Reported figures, not investment advice.

Based on Quick Heal Technologies Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.

The short version

Q2 FY27 Revenue: ₹64.9 Cr, down 22.3% YoY (Page 32, 14) - Enterprise Revenue Q2 FY27: ₹35.5 Cr, down 3.9% YoY (Page 32) - Consumer Revenue Q2 FY27: ₹35.8 Cr, down 39.8% YoY (Page 32) - Consolidated Re Q2 FY27 EBITDA: ₹2.3 Cr, down 75.2% YoY from ₹9.2 Cr in Q2 FY26 (Page 32, 42, 14) - Q2 FY27 EBITDA Margin: 3.5%, down from 11.1% in Q2 FY26 (Page 42, 14) - Q2 FY27 Profit After Tax (PAT): ₹5.8 Cr, down 26.8% YoY from ₹7.9 Cr in Q2 FY26 (Page 32, 42, 14) - Q2 FY27 PAT Margin: 8.9%, down from 9.5% in Q2 FY26 (Page 42, 14)

From Quick Heal Technologies Ltd's Q2 FY27 earnings-call transcript · updated 28 Oct 2026.

Revenue & Sales Performance

  • Q2 FY27 Revenue: ₹64.9 Cr, down 22.3% YoY (Page 32, 14)
  • Enterprise Revenue Q2 FY27: ₹35.5 Cr, down 3.9% YoY (Page 32)
  • Consumer Revenue Q2 FY27: ₹35.8 Cr, down 39.8% YoY (Page 32)
  • Consolidated Revenue Q2 FY27: ₹64.9 Cr vs ₹83.5 Cr in Q2 FY26 (Page 42)
  • Standalone Revenue Q2 FY27: ₹64.94 Cr vs ₹83.52 Cr in Q2 FY26 (Page 10)

2 more points from Quick Heal Technologies Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Quick Heal Technologies Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • The standalone cash flow statement (Page 13) shows capital expenditure (capex) for property, plant, and equipment and intangible assets (including capital work-in-progress and capital advances) of INR 12.55 Cr for the period ended September 30, 2026, INR 13.56 Cr for the period ended September 30, 2025, and INR 15.42 Cr for the year ended March 31, 2026.
  • The balance sheet (Pages 8, 43, 12) reflects a decrease in property, plant, and equipment from INR 87.6 Cr (Mar 31, 2026) to INR 62.7 Cr (Sep 30, 2026) and an increase in capital work-in-progress to INR 1.3 Cr as of Sep 30, 2026.

Top-ranked in IT - Software

Ranked on what management guided this quarter

Guidance-ranked
1Workmates Core2
Rev 1Mar 1
2Virtual Galaxy
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 2
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Quick Heal Technologies Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

- The investor presentation reports an **Order Book of INR 57 Cr+** as a key business highlight in H1 FY27 (Page 31). - It also mentions **Deferred Revenue of INR 48.3 Cr** as of Q2 FY27 (Page 31), which can be considered as pending revenue from orders. - The deferred revenue noted in Q1 FY27 was INR 52.3 Cr, showing a slight decrease by Q2 FY27 (Page 31). These are the only explicit figures related to order inflow, order book, or pending orders stated in the presentation.

Quick Heal Technologies Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹65 Cr, net profit ₹6 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Quick Heal Technologies Ltd's management said in earlier quarters

Others in IT - Software this season

  • 3i Infotech Ltd (Q2 FY27)

    Q2 FY27 consolidated operating revenue: ₹182.0 crore, up 4.1% YoY from ₹174.9 crore in Q2 FY26. Key investor presentation takeaways from 3i Infotech Ltd's Q2 FY

  • InfoBeans Tech. (Q2 FY27)

    3,780 Lakhs increase, approximately 30.1% growth . Key investor presentation takeaways from InfoBeans Technologies Ltd's Q2 FY27 investor presentation — and how

  • Hexaware Technologies Ltd (Q2 FY27)

    USD 411.9 million (+4.3% YoY, +1.6% QoQ) . Key investor presentation takeaways from Hexaware Technologies Ltd's Q2 FY27 investor presentation — and how it ranks

  • Zensar Technologies Ltd (Q2 FY27)

    Year-on-year revenue growth: 2.0% in constant currency, 11.5% in INR terms . Key investor presentation takeaways from Zensar Technologies Ltd's Q2 FY27 investor

Compare:vs TCSvs Infosys Ltdvs HCL Technologies

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Quick Heal Technologies Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Quick Heal Technologies Ltd Q2 FY27 results?

Q2 FY27 Revenue: ₹64.9 Cr, down 22.3% YoY (Page 32, 14) - Enterprise Revenue Q2 FY27: ₹35.5 Cr, down 3.9% YoY (Page 32) - Consumer Revenue Q2 FY27: ₹35.8 Cr, down 39.8% YoY (Page 32) - Consolidated Re Q2 FY27 EBITDA: ₹2.3 Cr, down 75.2% YoY from ₹9.2 Cr in Q2 FY26 (Page 32, 42, 14) - Q2 FY27 EBITDA Margin: 3.5%, down from 11.1% in Q2 FY26 (Page 42, 14) - Q2 FY27 Profit After Tax (PAT): ₹5.8 Cr, down 26.8% YoY from ₹7.9 Cr in Q2 FY26 (Page 32, 42, 14) - Q2 FY27 PAT Margin: 8.9%, down from 9.5% in Q2 FY26 (Page 42, 14)

What is Quick Heal Technologies Ltd share price analysis?

Quick Heal Technologies Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹750 Cr. Investors should review the full earnings analysis for detailed insights.

Is Quick Heal Technologies Ltd planning capital expenditure?

The standalone cash flow statement (Page 13) shows capital expenditure (capex) for property, plant, and equipment and intangible assets (including capital work-in-progress and capital advances) of INR 12.55 Cr for the period ended September 30, 2026, INR 13.56 Cr for the period ended September 30, 2025, and INR 15.42 Cr for the year ended March 31, 2026.

Keep Quick Heal Technologies Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.